News
Back in mid-June, Alzforum reported on how the AD research field was being buffeted by cuts in funding to the National Institutes of Health (Jun 2025 news; Jun 2025 news). At the time, scientists felt ...
Phospho-tau217 has emerged as an excellent marker of the presence of amyloid pathology in the brain, but for markers of neurofibrillary tangles, fragments of tau’s microtubule binding region have a ...
“We have a positive trial,” announced Laura Baker of Wake Forest University, North Carolina, drawing cheers during her plenary at the 2025 Alzheimer’s Association International Conference (AAIC) in ...
Lithium is one of the oldest drugs in psychiatric medicine, commonly prescribed for bipolar disorder. Now, a study in the August 6 Nature lays out a new case for the potential use of this metal ...
The Dominantly Inherited Alzheimer Network has been at the vanguard of AD immunotherapy development, launching the first secondary and primary prevention trials, as well as the first study of ...
At this year’s Alzheimer’s Association International Conference, held July 27-31 in Toronto, scientists introduced a plethora of new assays for biomarkers that could improve diagnosis and tracking of ...
With two amyloid immunotherapies on the market in many countries, scientists are eager for information on how durable their clinical effects will be. At this year’s Alzheimer’s Association ...
Statins do not help prevent Alzheimer’s disease, but another cholesterol-controlling drug just might. Obicetrapib blocks cholesteryl esters being transferred from the “good” high-density lipoproteins ...
Computational biology has put the human brain vasculature in its crosshairs. On July 23 in Neuron, scientists led by Andrew Yang, University of California, San Francisco, report a multiomic approach ...
03 October 2025 DOWNLOAD TO YOUR CALENDAR Dublin, Ohio and Online View Conference Website ...
ApoeCh and PS19 mice were intercrossed to generate the following four genotypes: (i) wild-type (WT), (ii) homozygous for the Apoe Christchurch allele (ApoeCh), (iii) hemizygous for the MAPT P301S ...
Part 1 of 6: Chicago—ALS Database Opens for Business Part 2 of 6: Chicago—ALS Protein SOD1 Painted as Disease Template Part 3 of 6: Chicago—ALS Clinical Trials: New Hope After Phase 3 Setbacks Part 4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results